Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Shire Pharmaceuticals Ireland Limited, Block 2 & 3 Miesian Plaza, 50–58 Baggot Street Lower, Dublin 2, Ireland
Resolor 1 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet (tablet). White to off-white, round, biconvex tablets marked “PRU 1” on one side. |
Each film-coated tablet contains 1 mg prucalopride (as succinate).
Excipients with known effect: Each film-coated tablet contains 142.5 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Prucalopride |
Prucalopride is a dihydrobenzofurancarboxamide with gastrointestinal prokinetic activities. Prucalopride is a selective, high affinity serotonin (5-HT4) receptor agonist, which is likely to explain its prokinetic effects. |
List of Excipients |
---|
Tablet core: Lactose monohydrate Tablet coating: Hypromellose |
Aluminium/aluminium perforated unit dose blisters (calendar marked) containing 7 tablets. Each pack contains 7 × 1, 14 × 1, 28 × 1 or 84 × 1 film-coated tablet.
Not all pack sizes may be marketed.
Shire Pharmaceuticals Ireland Limited, Block 2 & 3 Miesian Plaza, 50–58 Baggot Street Lower, Dublin 2, Ireland
EU/1/09/581/001 (28 tablets)
EU/1/09/581/003 (7 tablets)
EU/1/09/581/005 (14 tablets)
EU/1/09/581/007 (84 tablets)
Date of first authorisation: 15 October 2009
Date of latest renewal: 06 June 2014
Drug | Countries | |
---|---|---|
RESOLOR | Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.